Researchers enrolling patients in trials for a possible antiviral treatment for COVID-19

As the pandemic continues, physicians and researchers across the world are working doggedly to find ways to mitigate the toll of COVID-19, especially among populations experiencing infection surges. While many scientists are striving to create a vaccine, others Read More »

July 23rd, 2020|Announcements, Clinical Studies, COVID-19, Keck Net Intranet|

USC Norris Comprehensive Cancer Center receives $5 million for cancer drug discoveries

On June 29, USC Norris Comprehensive Cancer Center, Keck Medicine of USC and the Read More »

June 30th, 2020|Announcements, Clinical Studies, Keck Net Intranet|

Keck Medicine of USC launches clinical trial to study anti-inflammatory drug as treatment for COVID-19

Keck Medicine of USC physicians are launching a clinical trial to evaluate the efficacy and safety of baricitinib, an anti-inflammatory drug approved by the Food and Drug Read More »

May 6th, 2020|Announcements, Clinical Studies, COVID-19, Keck Net Intranet|

Keck School announces new prioritization process for COVID-19 research

The Keck School of Medicine of USC has established a process to rapidly evaluate research related to COVID-19 and open opportunities for care to clinicians and patients, according to a memo distributed April 4.

The new Read More »

April 13th, 2020|Announcements, Clinical Studies, COVID-19, Keck Net Intranet|

Physician-scientists pioneer new surgical approach to treat progressive blindness

Dry age-related macular degeneration (dry AMD) poses a significant clinical challenge. It is one of the leading causes of progressive blindness, robbing millions of people over the age of 65 of their central vision, and it often hinders Read More »

April 7th, 2020|Announcements, Clinical Studies, Keck Net Intranet|